ENSC
Price
$2.22
Change
+$0.04 (+1.83%)
Updated
Jun 26, 04:59 PM (EDT)
Capitalization
5.26M
NEUP
Price
$6.80
Change
-$0.20 (-2.86%)
Updated
Jun 26, 04:59 PM (EDT)
Capitalization
12.78M
Interact to see
Advertisement

ENSC vs NEUP

Header iconENSC vs NEUP Comparison
Open Charts ENSC vs NEUPBanner chart's image
Ensysce Biosciences
Price$2.22
Change+$0.04 (+1.83%)
Volume$634
Capitalization5.26M
Neuphoria Therapeutics
Price$6.80
Change-$0.20 (-2.86%)
Volume$2.15K
Capitalization12.78M
ENSC vs NEUP Comparison Chart in %
Loading...
ENSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NEUP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ENSC vs. NEUP commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENSC is a Buy and NEUP is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 27, 2025
Stock price -- (ENSC: $2.22 vs. NEUP: $6.80)
Brand notoriety: ENSC and NEUP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ENSC: 1% vs. NEUP: 241%
Market capitalization -- ENSC: $5.26M vs. NEUP: $12.78M
ENSC [@Biotechnology] is valued at $5.26M. NEUP’s [@Biotechnology] market capitalization is $12.78M. The market cap for tickers in the [@Biotechnology] industry ranges from $301.01B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ENSC’s FA Score shows that 1 FA rating(s) are green whileNEUP’s FA Score has 1 green FA rating(s).

  • ENSC’s FA Score: 1 green, 4 red.
  • NEUP’s FA Score: 1 green, 4 red.
According to our system of comparison, NEUP is a better buy in the long-term than ENSC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ENSC’s TA Score shows that 5 TA indicator(s) are bullish while NEUP’s TA Score has 6 bullish TA indicator(s).

  • ENSC’s TA Score: 5 bullish, 3 bearish.
  • NEUP’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both ENSC and NEUP are a good buy in the short-term.

Price Growth

ENSC (@Biotechnology) experienced а +4.23% price change this week, while NEUP (@Biotechnology) price change was +2.72% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.59%. For the same industry, the average monthly price growth was +34.25%, and the average quarterly price growth was +14.95%.

Reported Earning Dates

ENSC is expected to report earnings on May 13, 2025.

NEUP is expected to report earnings on May 20, 2025.

Industries' Descriptions

@Biotechnology (+3.59% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NEUP($12.8M) has a higher market cap than ENSC($5.26M). NEUP has higher P/E ratio than ENSC: NEUP (0.36) vs ENSC (0.02). NEUP YTD gains are higher at: 98.251 vs. ENSC (-72.727). NEUP has higher annual earnings (EBITDA): 192K vs. ENSC (-6.77M). NEUP has more cash in the bank: 17M vs. ENSC (3.05M). NEUP has less debt than ENSC: NEUP (172K) vs ENSC (257K). NEUP has higher revenues than ENSC: NEUP (15.7M) vs ENSC (0).
ENSCNEUPENSC / NEUP
Capitalization5.26M12.8M41%
EBITDA-6.77M192K-3,526%
Gain YTD-72.72798.251-74%
P/E Ratio0.020.366%
Revenue015.7M-
Total Cash3.05M17M18%
Total Debt257K172K149%
FUNDAMENTALS RATINGS
ENSC: Fundamental Ratings
ENSC
OUTLOOK RATING
1..100
28
VALUATION
overvalued / fair valued / undervalued
1..100
27
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
92
P/E GROWTH RATING
1..100
70
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ENSCNEUP
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
67%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 2 days ago
89%
Declines
ODDS (%)
Bearish Trend 17 days ago
90%
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ENSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NEUP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MPTI41.242.48
+6.40%
M-tron Industries
VVPR3.830.16
+4.36%
VivoPower International PLC
PKST13.220.09
+0.69%
Peakstone Realty Trust
HTHT34.280.23
+0.68%
H World Group Limited
IDCC227.27-3.23
-1.40%
InterDigital

ENSC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ENSC has been loosely correlated with MLLCF. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ENSC jumps, then MLLCF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENSC
1D Price
Change %
ENSC100%
+1.83%
MLLCF - ENSC
37%
Loosely correlated
N/A
HNSBF - ENSC
33%
Loosely correlated
N/A
SYRE - ENSC
31%
Poorly correlated
+3.96%
NEUP - ENSC
31%
Poorly correlated
-2.86%
YMAB - ENSC
30%
Poorly correlated
-2.24%
More

NEUP and

Correlation & Price change

A.I.dvisor indicates that over the last year, NEUP has been loosely correlated with SYBX. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if NEUP jumps, then SYBX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEUP
1D Price
Change %
NEUP100%
-2.86%
SYBX - NEUP
64%
Loosely correlated
+1.67%
BRNS - NEUP
50%
Loosely correlated
+4.43%
CMND - NEUP
31%
Poorly correlated
-2.03%
ENSC - NEUP
31%
Poorly correlated
+1.83%
SLNO - NEUP
27%
Poorly correlated
-2.06%
More